Any Time Analysis


Serving Bryan * College Station* La Grange,
& Greater Brazos Valley

On Site and On-Call Anytime 24/7                     1 (866) 227-9065 Toll Free 

• Drug, Alcohol & C/TPA Services     • Paternity Testing     • DOT Physicals

• Work & School Physicals     • Pulmonary and Fit Testing     • Phlebotomy & Labwork

• Vison Screens    • School and Flu Shots   • HR Trainings


Trustworthy, Reliable, & Family Friendly


8:00 AM - 5:30 PM



12 NOON - 5:30 PM

(Both offices are closed Saturday & Sunday)

but we are always

on call...


Bryan office: 979-823-9000

La Grange:  979-968-3239




Latest Headlines

January 2, the Bryan and LaGrange sites merge under one ownership and management!

Any Time Analysis LaGrange was officially sold to the parent company of Any Time Analysis in Bryan.  Testing and collections will continue at 263 S Reynolds in LaGrange.  CEO, Brian Neal, assures everyone that operations will continue "business as usual" in LaGrange.  Neal also stated that there will be efforts to "leverage technology to streamline business activities and improve efficiencies.  We look forward to meeting the community's drug testing needs with excellent service."

Brian and his wife, JoAnnie, have managed the Bryan location since July of 2015.  They also are partners in Reliance Testing, located in Guam.




The U.S. Department of Transportation’s Pipeline and Hazardous Materials Safety Administration announced that during calendar year 2018, the minimum random drug testing rate will be increased to 50%.  The minimum rate for 2017 was 25%.  The increase is due to a positive rate of more than 1% during the year.


New DOT Rules in Effect beginning January 1, 2018

Part 40 Final Rule - DOT Summary of Changes
November 13, 2017, the Department of Transportation (DOT) published a final rule in the Federal Register (82 FR 52229).  

The final rule is effective January 1, 2018.

What does this mean for employees?

You will also be tested for four semi-synthetic opioids (i.e., hydrocodone, oxycodone, hydromorphone, oxymorphone).  Some common names for these semi-synthetic opioids include OxyContin®, Percodan®, Percocet®, Vicodin®, Lortab®, Norco®, Dilaudid®, Exalgo®.  In addition, you will no longer be tested for MDEA.

What does this mean for urine collectors?

The shy bladder process has been modified so that the collector will discard any specimen provided during the collection event when the employee does not provide a sufficient specimen by the end of the three hour wait period.

What does this mean for laboratories?

As an HHS-certified laboratory you will:
Add four semi-synthetic opioids: hydrocodone, oxycodone, hydromorphone; oxymorphone to your DOT testing panel;
Add MDA as an initial test analyte;
Remove testing for MDEA;
Add three more fatal flaws to the list of reasons when a laboratory would report a ‘rejected for testing’ specimen; and
Need to modify the reports [in Appendix B & C] you provide to employers and the DOT.
What does this mean for Medical Review Officers (MRO)?
Several of your MRO drug test review processes have been modified.  For example:
The term ‘prescription’ has been clarified;
You have authority to conduct D,L stereoisomer and THC-V testing; and
The timing when you communicate a significant safety risk has been modified.

What does this mean for alcohol technicians?

The list of NHTSA-approved Alcohol Screening Devices and Evidential Breath Testing Devices will appear on ODAPC’s website.
What does this mean for service agents?

Collectors, alcohol testing technicians, MROs, and Substance Abuse Professionals will be required to subscribe to ODAPC's list-serve at:
Unauthorized use of DOT-branded items (such as logos or emblems) on a service agent’s website, publications, etc., could be a basis for the DOT to initiate a Public Interest Exclusion proceeding.

What are some of the other changes to Part 40?

The DOT added a new section reiterating that, in the DOT testing program, only urine specimens can be collected and analyzed at HHS-certified laboratories.
The DOT added language further emphasizing the existing DOT prohibition on the use of DNA testing on DOT drug-testing specimens.

Where can I find a copy of the final rule?
You can view the final rule on ODAPC’s website
NOTE:   This document informally summarizes some of the important effects of the rule, but it is not a substitute for the rule and should not be relied upon to determine legal compliance with the rule.  ODAPC encourages affected entities, including employers and service agents, to review the final rule.


FMCSA Reduces Random Testing Rates for 2016

On December 24, 2015, the FMCSA announces that it is reducing the minimum annual percentage rate for random controlled substances testing for drivers of commercial motor vehicles (CMVs) requiring a commercial driver's license (CDL) from the current rate of 50 percent of the average number of driver positions to 25 percent of the average number of driver positions, effective in calendar year 2016


New Medical Cards Issued

The Revised Medical Cards are in and being issued at Any Time Analysis!


Survey: More teens using synthetic drugs

Synthetic drugs popular among teens.  Catch the story in USA Today by clicking on the following link: